Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3)

Market Cap	1.67B +37.7%
Revenue (ttm)	1.22B +19.5%
Net Income	222.31M +65.5%
EPS	4.13 +65.5%
Shares Out	53.77M
PE Ratio	7.52
Forward PE	n/a
Dividend	1.29 (4.15%)
Ex-Dividend Date	Apr 17, 2026

Volume	11,800
Average Volume	10,805
Open	31.18
Previous Close	31.19
Day's Range	30.81 - 32.00
52-Week Range	20.90 - 32.00
Beta	0.22
RSI	69.17
Earnings Date	May 7, 2026

About BVMF:OFSA3

Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including anti-inflammatories, antibiotics, anticoccidials, antimastitics, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, thera...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,086
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: OFSA3

Financial Performance

In 2025, BVMF:OFSA3's revenue was 1.22 billion, an increase of 19.54% compared to the previous year's 1.02 billion. Earnings were 222.31 million, an increase of 65.50%.